St. Jude Medical, Inc. (NYSE:STJ) Plans to Acquire Spinal Modulation Inc. In Coming Days

St. Jude Medical, Inc. (NYSE:STJ) is in talks to acquire Spinal Modulation Inc. The company has recently announced its plans to do so, in an attempt to target DRG stimulation technology. With this move the St. Jude Medical aims to expand its portfolio of treatments for chronic pain. Spinal Modulation Inc. is the manufacturer of […]

St. Jude Medical, Inc. (NYSE:STJ) Records Slower Than Expected Sales In International Markets In 3Q

Boston, MA 10/15/2014 (wallstreetpr) – St. Jude Medical, Inc. (NYSE:STJ) Chairman, President and CEO, Daniel Starks, said that its sales growth in international markets were slower than its expectations. However, it witnessed accelerated growth in the U.S. as a result of strength in innovation and new products like heart failure monitoring system of CardioMEMS. He […]

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways from Transcatheter Cardiovascular Therapeutics Conference

Boston, MA 09/16/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSE:GS) analysts have provided key takeaways from the 2014 Transcatheter Cardiovascular Therapeutics or TPT conference. Accordingly, they have retained their Buy rating on the shares of Abbott Pharmaceuticals (NYSE:ABT) and Edwards Lifesciences Corp (NYSE:EW) while they remained Neutral on St. Jude Medical, Inc. (NYSE:STJ) […]